HIGHLIGHTS
- who: December et al. from the Yangzhou University, China have published the paper: Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database, in the Journal: (JOURNAL)
- how: In this study the statistical methods of ROR and IC were used to mine the FAERS database for potential adverse effect signals of TAD. 4.4 TAD and fungal breakthrough infections Multiple unlabeled IMEs associated with fungal infections (e_g Aspergillus pneumoniae) were also identified in this study even after AEs of non-TAD antifungal drugs were used as analysis context.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.